Literature DB >> 12394902

Histology of the craniocervical junction in chronic rheumatoid arthritis: a clinicopathologic analysis of 33 operative cases.

Michael F O'Brien1, Adrian T H Casey, Alan Crockard, Jean Pringle, John M Stevens.   

Abstract

STUDY
DESIGN: A histologic review of surgical specimens with clinical and radiographic correlations.
OBJECTIVE: To analyze the histopathology at the craniocervical junction in chronic rheumatoid arthritis (RA). SUMMARY OF BACKGROUND DATA: It has been assumed that the tissue identified on radiography at the craniocervical junction causing anterior spinal cord compression in patients with chronic RA is hypertrophic rheumatoid synovium. To date, no study has positively identified the histology of this tissue.
METHODS: Transoral resection of the dens and spinal cord decompression were performed in 33 myelopathic rheumatoid patients with craniocervical instability. The resected specimens were examined histologically.
RESULTS: Two unique histologic patterns were identified. Type I synovium has a recognizable synovial structure but without a hyperplastic synovial layer, significant inflammatory cell population, or lymphocytic infiltration typical of early active rheumatoid synovium. Type II synovium is a bland, fibrous, hypercellular tissue that is hypovascular, with little synovium and few inflammatory cells. Clinically and radiologically the two groups are distinct. Patients with Type II synovium are older ( = 0.008) and present with more advanced neurologic involvement caused by spinal cord compression ( = 0.0001). The mean difference in the spinal cord area between the two groups was 20.6 mm (95% confidence interval, 10.0-31.2 mm; = 0.004).
CONCLUSIONS: The histologic specimens suggest that ligamentous destruction is followed by replacement of the rheumatoid synovium with fibrous tissue, whereas the osseous structures reveal severe destruction secondary to mechanical instability, rather than to an acute inflammatory process. Early, preemptive surgical intervention may prevent the development of spinal cord injury caused by instability.

Entities:  

Mesh:

Year:  2002        PMID: 12394902     DOI: 10.1097/00007632-200210150-00012

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  7 in total

1.  Morphological and volumetric analysis of the development of atlantoaxial vertical subluxation in rheumatoid arthritis.

Authors:  Toshiyuki Dokai; Hideki Nagashima; Toru Okano; Yoshiro Nanjo; Yuji Kishimoto; Atsushi Tanida; Suguru Kakite; Hiroshi Hagino
Journal:  Yonago Acta Med       Date:  2013-03-01       Impact factor: 1.641

Review 2.  Cervical spine instability in rheumatoid arthritis.

Authors:  Filipa Camacho da Côrte; Nuno Neves
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-06-27

Review 3.  [Cervical myelopathy as a complication of rheumatoid arthritis].

Authors:  A C Arlt; J Steinmetz
Journal:  Z Rheumatol       Date:  2004-08       Impact factor: 1.372

4.  Relationship between the morphology of the atlanto-occipital joint and the radiographic results in patients with atlanto-axial subluxation due to rheumatoid arthritis.

Authors:  Haku Iizuka; Yasunori Sorimachi; Tsuyoshi Ara; Masahiro Nishinome; Takashi Nakajima; Yoichi Iizuka; Kenji Takagishi
Journal:  Eur Spine J       Date:  2008-04-04       Impact factor: 3.134

5.  MRI of the transverse and alar ligaments in rheumatoid arthritis: feasibility and relations to atlantoaxial subluxation and disease activity.

Authors:  Nils Vetti; Rikke Alsing; Jostein Kråkenes; Jarle Rørvik; Nils Erik Gilhus; Johan Gorgas Brun; Ansgar Espeland
Journal:  Neuroradiology       Date:  2010-03       Impact factor: 2.804

6.  Cervical myelopathy in rheumatoid arthritis.

Authors:  N Mukerji; N V Todd
Journal:  Neurol Res Int       Date:  2011-11-22

7.  Rationale and design of The Delphi Trial--I(RCT)2: international randomized clinical trial of rheumatoid craniocervical treatment, an intervention-prognostic trial comparing 'early' surgery with conservative treatment [ISRCTN65076841].

Authors:  Jasper F C Wolfs; Wilco C Peul; Maarten Boers; Maurits W van Tulder; Ronald Brand; Hans J C van Houwelingen; Raph T W M Thomeer
Journal:  BMC Musculoskelet Disord       Date:  2006-02-16       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.